Elevance Health, Inc. (ELV) Form 10-Q — Jul 15, 2026
Elevance Health reported total operating revenue of $49,826 million for the second quarter of 2026, an increase of 0.8% compared to the prior year period, driven by premium rate increases and growth in CarelonRx product revenues. Despite the revenue growth, shareholders’ net income decreased 16.1% to $1,463 million, with diluted earnings per share falling to $6.71 from $7.72 a year ago. The decline in profitability was primarily attributed to a decrease in operating gain within the Health Benefits and Carelon Services segments, alongside a loss contingency accrual related to Medicare Advantage risk adjustment data.
Key figures
- Eps
- 6.71
- Revenue
- 49826
- Net Income
- 1454
- Revenue Yoy
- 0.8%
- Cash Position
- 10232
Price after filing
Close on the filing date to close N calendar days later (from $425.17). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.